News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Schering-Plough Corporation (SGP) Appoints Karl D. Salnoske Vice President And Chief Information Officer

10/19/2005 5:12:17 PM

KENILWORTH, N.J., Nov. 24 /PRNewswire-FirstCall/ -- Schering-Plough Corporation today announced that Karl D. Salnoske has been appointed vice president and chief information officer, effective immediately.

Salnoske is responsible for directing the planning, acquisition, development and operation of computer, telecommunication and information systems for all offices globally. He is also responsible for establishing the technical infrastructure and setting strategic guidelines for use of information systems technology throughout the company.

Salnoske joins Schering-Plough from Adaptive Trade, a start-up firm that provided next-generation decision optimization tools to the energy and process manufacturing industries to reduce costs, streamline operations and maximize profitability, where he was president and chief executive officer. Prior to this position, he served as general manager, software solutions, and vice president, global services, at IBM. While at IBM, he was responsible for more than 400 professionals providing key consulting services to more than 2,000 firms across a number of industries on a worldwide basis. Also in his career, Salnoske has held leadership positions with increasing responsibility at McKinsey & Co., Telenet, Xerox and Exxon.

Salnoske holds a bachelor's of science degree in electrical engineering from Virginia Polytechnic Institute in Blacksburg, Va., where he serves on the Advisory Board for the Department of Electrical and Computer Engineering.

Salnoske reports to Robert Bertolini, executive vice president and chief financial officer.

Schering-Plough is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians, patients and customers served by its more than 30,000 people around the world. The company is based in Kenilworth, N.J., and its Web site is

Schering-Plough Corporation

CONTACT: Media - Steve Galpin, Jr., +1-908-298-7415, or Investor - JanetBarth and Alex Kelly, +1-908-298-7436, all of Schering-Plough

Read at

comments powered by Disqus